Publication | Closed Access
Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects
14
Citations
20
References
2018
Year
Molecular PharmacologyHealthy SubjectsSiponimod PharmacokineticsPharmacologyCyp2c9/3a4 InducerClinical PharmacologyExperimental PharmacologyPharmacotherapyMedicinePharmacokineticsDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1